Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

Rheumatology's other Nobel laureate.

Zvaifler NJ.

Arthritis Rheum. 2011 Sep;63(9):2838. doi: 10.1002/art.30561. No abstract available.

2.

Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis.

Chao J, Parker BA, Zvaifler NJ.

J Rheumatol. 2009 May;36(5):1087-8. doi: 10.3899/jrheum.080648. No abstract available.

PMID:
19435976
3.

Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab.

Rosengren S, Wei N, Kalunian KC, Zvaifler NJ, Kavanaugh A, Boyle DL.

Arthritis Res Ther. 2008;10(5):R105. doi: 10.1186/ar2497. Epub 2008 Sep 1.

4.

New causes of disease.

Zvaifler NJ.

Arthritis Rheum. 2008 Feb;58(2 Suppl):S66-8. doi: 10.1002/art.22950. No abstract available.

5.

Rosuvastatin: an independent analysis of risks and benefits.

Zipes DP, Zvaifler NJ, Glassock RJ, Gilman S, Muñoz A, Gogolak V, Gordis L, Dedon PC, Guengerich FP, Wasserman SI, Witztum JL, Wogan GN.

MedGenMed. 2006 Jun 14;8(2):73. Review.

6.

Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases.

Zvaifler NJ.

Arthritis Res Ther. 2006;8(3):210. Epub 2006 May 9. Review.

7.

Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.

Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, Reed JC, Zvaifler NJ, Kipps TJ.

Blood. 2005 Aug 1;106(3):1012-20. Epub 2005 Apr 28.

8.

Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines.

Ohata J, Zvaifler NJ, Nishio M, Boyle DL, Kalled SL, Carson DA, Kipps TJ.

J Immunol. 2005 Jan 15;174(2):864-70.

9.

Regional analysis of p53 mutations in rheumatoid arthritis synovium.

Yamanishi Y, Boyle DL, Rosengren S, Green DR, Zvaifler NJ, Firestein GS.

Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10025-30. Epub 2002 Jul 15.

10.

Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis.

Marinova-Mutafchieva L, Williams RO, Funa K, Maini RN, Zvaifler NJ.

Arthritis Rheum. 2002 Feb;46(2):507-13.

11.

How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end.

Firestein GS, Zvaifler NJ.

Arthritis Rheum. 2002 Feb;46(2):298-308. Review. No abstract available.

12.

Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia.

Tsukada N, Burger JA, Zvaifler NJ, Kipps TJ.

Blood. 2002 Feb 1;99(3):1030-7.

PMID:
11807009
13.

Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis.

Yamanishi Y, Boyle DL, Pinkoski MJ, Mahboubi A, Lin T, Han Z, Zvaifler NJ, Green DR, Firestein GS.

Am J Pathol. 2002 Jan;160(1):123-30.

14.

Mesenchymal precursor cells.

Corr M, Zvaifler NJ.

Ann Rheum Dis. 2002 Jan;61(1):3-5. No abstract available.

15.
16.

Mesenchymal precursor cells in the blood of normal individuals.

Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, Maini RN.

Arthritis Res. 2000;2(6):477-88. Epub 2000 Aug 31.

17.

Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.

Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M, Kipps TJ.

Blood. 2000 Oct 15;96(8):2655-63.

PMID:
11023495
18.

Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint.

Marinova-Mutafchieva L, Taylor P, Funa K, Maini RN, Zvaifler NJ.

Arthritis Rheum. 2000 Sep;43(9):2046-55.

19.

Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases.

Tak PP, Zvaifler NJ, Green DR, Firestein GS.

Immunol Today. 2000 Feb;21(2):78-82. Review.

PMID:
10652465
20.

p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis.

Tak PP, Smeets TJ, Boyle DL, Kraan MC, Shi Y, Zhuang S, Zvaifler NJ, Breedveld FC, Firestein GS.

Arthritis Rheum. 1999 May;42(5):948-53.

21.

Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene.

Aupperle KR, Boyle DL, Hendrix M, Seftor EA, Zvaifler NJ, Barbosa M, Firestein GS.

Am J Pathol. 1998 Apr;152(4):1091-8.

22.

Deficient Fas ligand expression by synovial lymphocytes from patients with rheumatoid arthritis.

Cantwell MJ, Hua T, Zvaifler NJ, Kipps TJ.

Arthritis Rheum. 1997 Sep;40(9):1644-52.

PMID:
9324019
23.

Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium.

Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR.

Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10895-900.

24.

Anticytokine therapy in rheumatoid arthritis.

Firestein GS, Zvaifler NJ.

N Engl J Med. 1997 Jul 17;337(3):195-7. No abstract available.

PMID:
9219708
25.

Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions.

Zvaifler NJ, Tsai V, Alsalameh S, von Kempis J, Firestein GS, Lotz M.

Am J Pathol. 1997 Mar;150(3):1125-38.

26.

A retrospective analysis of the pathogenesis of rheumatoid arthritis.

Zvaifler NJ.

Rev Rhum Engl Ed. 1996 Dec;63(11):791-6. Review. No abstract available.

PMID:
9010965
27.

Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium.

Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ.

Am J Pathol. 1996 Dec;149(6):2143-51.

28.

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.

Hörkkö S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL.

J Clin Invest. 1996 Aug 1;98(3):815-25.

29.

Apoptosis in rheumatoid arthritis synovium.

Firestein GS, Yeo M, Zvaifler NJ.

J Clin Invest. 1995 Sep;96(3):1631-8.

30.

Rheumatoid arthritis. The multiple pathways to chronic synovitis.

Zvaifler NJ.

Lab Invest. 1995 Sep;73(3):307-10. No abstract available.

PMID:
7564263
31.

Low prevalence of HIV-1 proviral DNA in peripheral blood monocytes and dendritic cells from HIV-1-infected individuals.

Hsia K, Tsai V, Zvaifler NJ, Spector SA.

AIDS. 1995 Apr;9(4):398-9. No abstract available.

PMID:
7794548
32.

Macrophages and the synovial lining.

Zvaifler NJ.

Scand J Rheumatol Suppl. 1995;101:67-75. Review. No abstract available.

PMID:
7747134
33.

Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis.

Zvaifler NJ, Firestein GS.

Arthritis Rheum. 1994 Jun;37(6):783-9. Review. No abstract available.

PMID:
8003048
34.

Early synovitis--synoviocytes and mononuclear cells.

Zvaifler NJ, Boyle D, Firestein GS.

Semin Arthritis Rheum. 1994 Jun;23(6 Suppl 2):11-6. Review.

PMID:
7939726
35.

Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis.

Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP.

Arthritis Rheum. 1994 May;37(5):644-52.

PMID:
8185691
36.

The role of T cells in rheumatoid arthritis.

Firestein GS, Zvaifler NJ.

Ann Rheum Dis. 1993 Oct;52(10):765. No abstract available.

38.

Cytokine-induced differentiation of cultured nonadherent macrophages.

Tsai V, Firestein GS, Arend W, Zvaifler NJ.

Cell Immunol. 1992 Oct 1;144(1):203-16.

PMID:
1382865
39.

Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes.

Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Gracia JM, Zvaifler NJ, Firestein GS.

J Immunol. 1992 Aug 15;149(4):1424-31.

PMID:
1380043
40.

IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium.

Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, Yu C, Zvaifler NJ.

J Immunol. 1992 Aug 1;149(3):1054-62.

PMID:
1386092
41.

High percentage of CD8+, Leu-7+ cells in rheumatoid arthritis synovial fluid.

Burns CM, Tsai V, Zvaifler NJ.

Arthritis Rheum. 1992 Aug;35(8):865-73.

PMID:
1379428
43.

Immunopathogenesis of rheumatoid arthritis.

Firestein GS, Zvaifler NJ.

Immunol Ser. 1991;54:141-61. Review. No abstract available.

PMID:
1954274
45.

The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa.

Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT, et al.

Arthritis Rheum. 1990 Aug;33(8):1088-93.

PMID:
1975174
47.

How important are T cells in chronic rheumatoid synovitis?

Firestein GS, Zvaifler NJ.

Arthritis Rheum. 1990 Jun;33(6):768-73. Review. No abstract available. Erratum in: Arthritis Rheum 1990 Sep;33(9):1437.

PMID:
2194461
49.

Transforming growth factor-beta 1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation.

Broide DH, Wasserman SI, Alvaro-Gracia J, Zvaifler NJ, Firestein GS.

J Immunol. 1989 Sep 1;143(5):1591-7.

PMID:
2527268

Supplemental Content

Loading ...
Support Center